Format

Send to

Choose Destination
J Clin Med. 2018 Aug 15;7(8). pii: E218. doi: 10.3390/jcm7080218.

Primary Signet Ring Cell Carcinoma of the Prostate: A Rare Case Report.

Author information

1
Department of Urology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. alper_gok@hotmail.com.
2
Department of Urology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. drct36@gmail.com.
3
Department of Radiation Oncology, Gazi University Medical Faculty, Ankara 06560, Turkey. igk84@hotmail.com.
4
Department of Pathology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. guluslu@gmail.com.
5
Department of Urology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. igk84@hotmail.com.
6
Department of Urology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. drfatihsandikci61@hotmail.com.
7
Department of Urology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. osmanraifkarabacak@mynet.com.
8
Department of Urology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. leventsagnak@gmail.com.
9
Department of Urology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. hikmettopaloglu@hotmail.com.
10
Department of Urology, University of Health Sciences, Dışkapı Yıldırım Beyazıt Training and Research Hospital, Ankara 06030, Turkey. hamitersoy@gmail.com.

Abstract

Primary prostatic signet ring cell carcinoma is a rare form of cancer with a poor prognosis, which is generally treated with a traditional prostate adenocarcinoma therapy. This case report presents a 70-year-old diagnosed with primary prostatic signet ring cell carcinoma, treated with a combination of radiotherapy and hormone therapy and a 16 month survival without an evidence of the disease at follow up.

KEYWORDS:

carcinoma; prostate; radiotherapy; signet ring cell

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center